V Visa Inc. Class A

Lee Johnson Capital Management LLC has acquired a new position in AT&T Inc. during the third quarter, purchasing 89,100 shares valued at approximately $2.52 million. Other institutional investors like Vanguard Group Inc. and Norges Bank also hold significant stakes, with institutional investors and hedge funds collectively owning 57.10% of the company's stock. AT&T recently announced a quarterly dividend of $0.2775 per share, resulting in a 4.5% yield.

Generate Investment Management Ltd has acquired a new stake of 23,389 shares in The Sherwin-Williams Company (NYSE: SHW), valued at approximately $8.10 million during Q3. This investment comes as Sherwin-Williams reported strong Q3 earnings, surpassing revenue and EPS estimates, and provided positive FY2025 guidance. Analysts currently rate the stock a "Moderate Buy" with an average price target of $390.07.

Generate Investment Management Ltd significantly reduced its stake in Lam Research Corporation (NASDAQ:LRCX) by selling 284,473 shares, decreasing its holdings by 62.2%. Despite this reduction, Lam Research remains Generate Investment Management's 26th largest position, making up approximately 1.2% of its investment portfolio. Other institutional investors like Vanguard Group Inc. and State Street Corp, however, increased their positions in the semiconductor company.

Calamos Wealth Management LLC increased its stake in International Business Machines (IBM) by 75.7%, adding 3,589 shares to own a total of 8,328 shares valued at approximately $2.35 million. Other institutional investors like Vanguard, State Street, and Geode Capital Management also significantly boosted their positions in IBM. The article also highlights IBM's strong Q3 earnings, its strategic positioning in AI and quantum computing, and a consensus "Moderate Buy" rating from analysts with an average price target of $293.38.

Calamos Advisors LLC significantly increased its stake in Thermo Fisher Scientific Inc. (NYSE:TMO) by 41.8% in Q3, now owning 147,700 shares valued at approximately $71.64 million. Despite this, company insiders have been net sellers, with CEO Marc N. Casper selling 17,104 shares and VP Lisa P. Britt selling 10,225 shares. The medical research company reported strong Q3 earnings, beating expectations, and authorized a $5.0 billion share buyback program.

Visa Inc. announced new conversion rates for its class B-1 and B-2 common stock after depositing $500 million into its U.S. litigation escrow account as part of its retrospective responsibility plan. This action, effective December 23, resulted in a decrease in conversion rates for both stock classes, effectively reducing their as-converted share counts. The change, which Visa states has a similar effect on earnings per share as repurchasing class A common stock, aligns with the company's strong financial performance and history of dividend payments.